Log on / register
Feedback | Support
Frequency of CHEK2*1100delC in New York breast cancer cases and controls.
Offit K, Pierce H, Kirchhoff T, Kolachana P, Rapaport B, Gregersen P, Johnson S, Yossepowitch O, Huang H, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N
BMC Med Genet 2003 Jan 15, 4:1
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.
CHEK2 Breast Cancer Case-Control Consortium
Am J Hum Genet 2004 Jun, 74:1175-82
[PubMed Central] [PubMed] [Related articles]

2.
CHEK2 is a multiorgan cancer susceptibility gene.
Cybulski C, Górski B, Huzarski T, Masoj B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymaska A, Szymaska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubiski J
Am J Hum Genet 2004 Dec, 75:1131-5
[PubMed Central] [PubMed] [Related articles]

3.
Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.
Einarsdóttir K, Humphreys K, Bonnard C, Palmgren J, Iles MM, Sjölander A, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedrén S
PLoS Med 2006 Jun, 3:e168
[PubMed Central] [PubMed] [Related articles]

4.
*** Unable to retrieve article 16671833 ***

[PubMed Central] [PubMed] [Related articles]


This article is also cited by 4 articles in BioMed Central

printer friendly 
to  [Help]

© 1999-2008 BioMed Central Ltd unless otherwise stated